Revelation Biosciences, Inc. (REVB) Financials
REVB Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 14.2 million | 5.4 million |
2023-06-30 | 16.0 million | 4.6 million |
2023-03-31 | 18.1 million | 8.1 million |
2022-12-31 | 5.5 million | 4.5 million |
REVB Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -1.7 million | 32096 |
2023-06-30 | -2.0 million | 59435 |
2023-03-31 | -1.6 million | 32095 |
2022-12-31 | -947467 | 32361 |
REVB Net Income
Graph available only for supporters. Become a supporter to see it.
Date | Net Income |
---|---|
2023-09-30 | -2.6 million |
2023-06-30 | -1.4 million |
2023-03-31 | 6.2 million |
2022-12-31 | -1.2 million |
REVB Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 14.0 million | - | - |
2023-06-30 | 15.7 million | - | - |
2023-03-31 | 17.7 million | - | - |
2022-12-31 | 5.3 million | - | - |
REVB Shares Outstanding
REVB Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 1.7 million | 1.1 million | - |
2023-06-30 | - | 909278 | 1.0 million | - |
2023-03-31 | - | 525273 | 1.1 million | - |
2022-12-31 | - | 339971 | 878356 | - |
REVB Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 6262 |
2023-06-30 | - | 6262 |
2023-03-31 | - | 6263 |
2022-12-31 | - | 6262 |
REVB
Price: $2.37
52 week price:
Earnings Per Share: -0.53 USD
P/E Ratio: -1.19
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 562000
Market Capitalization: 3.4 million